Welcome to our dedicated page for Therma Bright news (Ticker: TBRIF), a resource for investors and traders seeking the latest updates and insights on Therma Bright stock.
Therma Bright Inc. (TBRIF) delivers cutting-edge advancements in diagnostic technologies and medical devices through strategic partnerships and proprietary innovations. This news hub provides investors and healthcare professionals with verified updates on the company's progress in respiratory health solutions, vascular compression therapies, and stroke care technologies.
Access official press releases covering regulatory milestones like HCPCS designations, AI-driven diagnostic platform developments, and strategic collaborations with industry pioneers. Our curated collection ensures transparent tracking of Therma Bright's dual growth strategy: direct commercialization of medical devices and returns from targeted investments.
Discover updates categorized for quick navigation, including product approvals, clinical trial results, partnership announcements, and financial disclosures. All content is sourced directly from company filings and vetted industry channels to maintain accuracy.
Bookmark this page for streamlined access to Therma Bright's evolving role in shaping next-generation healthcare solutions. Check regularly for insights into how the company balances technological innovation with strategic market expansion.
Therma Bright Inc. (TBRIF), a developer of medical device technologies, provided a market update.
The company successfully raised $1M CAD through a private placement, intending to invest in its Digital Cough Analyzer and InStatin Inc., along with covering debts and working capital.
The Venowave device awaits permanent HCPCS and CPT codes, potentially expanding its market reach.
Therma is working with the FDA on the regulatory requirements for its AI-powered Digital Cough Analyzer.
Investments in Inretio and InStatin show promise, with Therma holding significant stakes in both companies.
A strategic review is ongoing to explore various options to maximize shareholder value.
Therma Bright (TSXV: THRM, OTCQB: TBRIF) announced it has completed debt settlements by issuing 19,250,000 common shares at $0.01 per share, settling an aggregate debt of $192,500. These shares are subject to a hold period until October 20, 2024. CEO Rob Fia participated in the debt settlement, receiving 8,500,000 shares for $85,000 of debt, which is a related party transaction under MI 61-101. Prior to this, Fia owned 28,718,744 shares (7.2% of Therma's outstanding shares). Post-transaction, he now owns 37,218,744 shares, representing 8.8% of the total outstanding shares. On a partially diluted basis, Fia's ownership could rise to 13.3%. Fia's acquisition is for investment purposes and he may change his holdings in the future. Further details can be found on SEDAR+.
Therma Bright has completed the first tranche of its non-brokered private placement, raising $854,500 by issuing 85,450,000 units at $0.01 each. The proceeds will fund investments in Digital Cough Technology and InStatin Inc, cover management and director debts, investor relations, and general working capital. CEO Rob Fia purchased 17,500,000 units for $175,000, increasing his stake to 7.2%. Allele Communications will provide investor relations services for $7,500 per month under a new consulting agreement. The securities are subject to a hold period until October 11, 2024.
Therma Bright, a developer of diagnostic and medical device technologies, announces a non-brokered private placement offering up to $1,000,000 by issuing 100,000,000 units at $0.01 per unit. Each unit includes one common share and a half-warrant, with full warrants exercisable over three years at $0.05 in the first year and $0.10 in the subsequent years. The proceeds will fund their Digital Cough technology, pay debts, and support general working capital. The offering is expected to close by June 7, 2024, pending regulatory approvals. Additionally, Therma Bright has granted stock options and warrants to directors, officers, consultants, and entered into debt settlements issuing common shares.
FAQ
What is the current stock price of Therma Bright (TBRIF)?
What is the market cap of Therma Bright (TBRIF)?
